Limertinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Limertinib, covering 2025-05-21 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression [Phase 2]